CRISPR gene editing therapy cuts LDL cholesterol in small study

A CRISPR-based gene editing therapy dramatically reduced levels of low-density lipoprotein, often called “bad cholesterol,” and triglycerides in patients with heart disease, a new study found.

Some researchers said that the treatment,…